Importantly, CXCL9 was also regulated by IFNγ and LIF in patient-derived TAMs (CD11b+ CD14+) obtained from fresh human GBM tumors (Fig. 3d, Supplementary Fig. 7b, c). The gene discussed is LIF; the disease is glioblastoma.